HUP0402023A2 - Anasztrozol felhasználása korai stádiumú emlőrákban szenvedő, véglegessé vált menopauzájú nőbetegek kezelésére alkalmas gyógyszerkészítmények előállításához - Google Patents
Anasztrozol felhasználása korai stádiumú emlőrákban szenvedő, véglegessé vált menopauzájú nőbetegek kezelésére alkalmas gyógyszerkészítmények előállításáhozInfo
- Publication number
- HUP0402023A2 HUP0402023A2 HU0402023A HUP0402023A HUP0402023A2 HU P0402023 A2 HUP0402023 A2 HU P0402023A2 HU 0402023 A HU0402023 A HU 0402023A HU P0402023 A HUP0402023 A HU P0402023A HU P0402023 A2 HUP0402023 A2 HU P0402023A2
- Authority
- HU
- Hungary
- Prior art keywords
- anastrozole
- breast cancer
- post
- preparation
- treatment
- Prior art date
Links
- 206010006187 Breast cancer Diseases 0.000 title abstract 2
- 208000026310 Breast neoplasm Diseases 0.000 title abstract 2
- YBBLVLTVTVSKRW-UHFFFAOYSA-N anastrozole Chemical compound N#CC(C)(C)C1=CC(C(C)(C#N)C)=CC(CN2N=CN=C2)=C1 YBBLVLTVTVSKRW-UHFFFAOYSA-N 0.000 title abstract 2
- 229960002932 anastrozole Drugs 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000009245 menopause Effects 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000005740 tumor formation Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4196—1,2,4-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Treatment Of Metals (AREA)
Abstract
A találmány tárgya az anasztrozol vagy gyógyászatilag alkalmazható sóifelhasználása korai stádiumú emlőrákban szenvedő, véglegessé váltmenopauzájú nőbetegeken a rák kiújulási arányának és/vagy újellenoldali primer tumor kialakulási arányának csökkentésére alkalmasgyógyszerkészítmények gyártásához. Ó
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0129457.8A GB0129457D0 (en) | 2001-12-10 | 2001-12-10 | Method of treatment |
PCT/GB2002/005554 WO2003053438A1 (en) | 2001-12-10 | 2002-12-06 | Use of anastrozole for the treatment of post-menopausal women having early breast cancer |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0402023A2 true HUP0402023A2 (hu) | 2005-01-28 |
HUP0402023A3 HUP0402023A3 (en) | 2008-08-28 |
Family
ID=9927290
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0402023A HUP0402023A3 (en) | 2001-12-10 | 2002-12-06 | Use of anastrozole in the preparation of pharmaceutical compositions for the treatment of post-menopausal women having early breast cancer |
Country Status (29)
Country | Link |
---|---|
US (1) | US20050165081A1 (hu) |
EP (2) | EP1997492A1 (hu) |
JP (2) | JP5335173B2 (hu) |
KR (1) | KR100858946B1 (hu) |
CN (1) | CN100408036C (hu) |
AT (1) | ATE406160T1 (hu) |
AU (1) | AU2002347371B2 (hu) |
BR (1) | BR0214798A (hu) |
CA (1) | CA2468965C (hu) |
CO (1) | CO5590926A2 (hu) |
CY (1) | CY1108462T1 (hu) |
DE (1) | DE60228616D1 (hu) |
DK (1) | DK1455781T3 (hu) |
ES (1) | ES2303811T3 (hu) |
GB (1) | GB0129457D0 (hu) |
HK (1) | HK1069335A1 (hu) |
HU (1) | HUP0402023A3 (hu) |
IL (1) | IL162150A0 (hu) |
IS (1) | IS7300A (hu) |
MX (1) | MXPA04005394A (hu) |
NO (1) | NO20042912L (hu) |
NZ (1) | NZ533106A (hu) |
PL (1) | PL369411A1 (hu) |
PT (1) | PT1455781E (hu) |
RU (1) | RU2320339C2 (hu) |
SI (1) | SI1455781T1 (hu) |
UA (1) | UA79443C2 (hu) |
WO (1) | WO2003053438A1 (hu) |
ZA (1) | ZA200404260B (hu) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
US8436029B2 (en) * | 2004-03-19 | 2013-05-07 | Transform Pharmaceuticals, Inc. | Pharmaceutical forms, and methods of making and using the same |
WO2005117864A1 (en) * | 2004-05-28 | 2005-12-15 | Astrazeneca Ab | Combination product comprising anastrozole and a dual prenyl transferase inhibitor |
CN100337625C (zh) * | 2004-08-30 | 2007-09-19 | 鲁南制药集团股份有限公司 | 阿那曲唑的分散片剂型 |
CN1304054C (zh) * | 2004-12-29 | 2007-03-14 | 山东蓝金生物工程有限公司 | 一种缓慢释放的抗癌药物组合物 |
GB0517674D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
GB0517673D0 (en) * | 2005-08-31 | 2005-10-05 | Astrazeneca Ab | Formulation |
WO2011130381A1 (en) * | 2010-04-13 | 2011-10-20 | Estrocept Diagnostics, Inc. | Diagnostic assays for breast cancer treatment and progression |
US10201549B2 (en) | 2013-06-14 | 2019-02-12 | Professional Compounding Centers Of America (Pcca) | Testosterone combined with anastrozole injection solutions |
CN103450099B (zh) * | 2013-09-06 | 2015-03-25 | 杭州华东医药集团新药研究院有限公司 | 阿那曲唑及其一水合物的新晶型、制备和用途 |
RU2548722C1 (ru) * | 2013-12-06 | 2015-04-20 | Федеральное государственное бюджетное учреждение "Национальный исследовательский центр "Курчатовский институт" | Противоопухолевое лекарственное средство пролонгированного действия на основе противоопухолевого препарата, ингибитора синтеза эстрогенов - анастрозола |
DE102014005513B4 (de) * | 2014-04-15 | 2018-03-15 | Sanoxsys Gmbh | Mittel zur Prävention und Therapie von Tumorerkrankungen |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8714013D0 (en) * | 1987-06-16 | 1987-07-22 | Ici Plc | (substituted-aralkyl)heterocyclic compounds |
AR034142A1 (es) * | 2000-09-08 | 2004-02-04 | Sloan Kettering Inst Cancer | Una composicion farmaceutica, metodo para fabricar un medicamento en base a dicha composicion y uso de la composicion |
GB0129457D0 (en) * | 2001-12-10 | 2002-01-30 | Astrazeneca Ab | Method of treatment |
-
2001
- 2001-12-10 GB GBGB0129457.8A patent/GB0129457D0/en not_active Ceased
-
2002
- 2002-06-12 UA UA20040705521A patent/UA79443C2/uk unknown
- 2002-12-06 KR KR1020047008806A patent/KR100858946B1/ko not_active IP Right Cessation
- 2002-12-06 NZ NZ533106A patent/NZ533106A/xx not_active IP Right Cessation
- 2002-12-06 CN CNB02824544XA patent/CN100408036C/zh not_active Ceased
- 2002-12-06 ES ES02783305T patent/ES2303811T3/es not_active Expired - Lifetime
- 2002-12-06 SI SI200230746T patent/SI1455781T1/sl unknown
- 2002-12-06 AT AT02783305T patent/ATE406160T1/de active
- 2002-12-06 RU RU2004121162/15A patent/RU2320339C2/ru not_active IP Right Cessation
- 2002-12-06 HU HU0402023A patent/HUP0402023A3/hu not_active Application Discontinuation
- 2002-12-06 JP JP2003554195A patent/JP5335173B2/ja not_active Expired - Lifetime
- 2002-12-06 PL PL02369411A patent/PL369411A1/xx not_active Application Discontinuation
- 2002-12-06 EP EP08162209A patent/EP1997492A1/en not_active Withdrawn
- 2002-12-06 EP EP02783305A patent/EP1455781B1/en not_active Revoked
- 2002-12-06 CA CA2468965A patent/CA2468965C/en not_active Expired - Fee Related
- 2002-12-06 DE DE60228616T patent/DE60228616D1/de not_active Expired - Lifetime
- 2002-12-06 MX MXPA04005394A patent/MXPA04005394A/es active IP Right Grant
- 2002-12-06 DK DK02783305T patent/DK1455781T3/da active
- 2002-12-06 BR BR0214798-0A patent/BR0214798A/pt not_active Application Discontinuation
- 2002-12-06 PT PT02783305T patent/PT1455781E/pt unknown
- 2002-12-06 US US10/498,444 patent/US20050165081A1/en not_active Abandoned
- 2002-12-06 AU AU2002347371A patent/AU2002347371B2/en not_active Revoked
- 2002-12-06 IL IL16215002A patent/IL162150A0/xx unknown
- 2002-12-06 WO PCT/GB2002/005554 patent/WO2003053438A1/en active IP Right Grant
-
2004
- 2004-05-31 ZA ZA2004/04260A patent/ZA200404260B/en unknown
- 2004-06-04 IS IS7300A patent/IS7300A/is unknown
- 2004-07-08 CO CO04064979A patent/CO5590926A2/es not_active Application Discontinuation
- 2004-07-09 NO NO20042912A patent/NO20042912L/no not_active Application Discontinuation
-
2005
- 2005-03-08 HK HK05101996.7A patent/HK1069335A1/xx not_active IP Right Cessation
-
2008
- 2008-10-29 CY CY20081101221T patent/CY1108462T1/el unknown
-
2010
- 2010-09-06 JP JP2010199008A patent/JP2011016828A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1069335A1 (en) | Use of anastrozole for the treatment of post-menopausal women having early breast cancer | |
HUP0400529A2 (hu) | Klórpromazin és pentamidin alkalmazása daganatképződéssel járó rendellenességek kezelésére szolgáló gyógyszerkészítmények előállítására | |
Spitler | A randomized trial of levamisole versus placebo as adjuvant therapy in malignant melanoma. | |
RU2007145489A (ru) | Фармацевтические композиции и способы лечения рака и его метастазов | |
MY127290A (en) | New use of flibanserin | |
HUP0401903A2 (hu) | Az ET-743 továbbfejlesztett alkalmazása daganatok kezelésére | |
BR0213684A (pt) | Uso de antagonistas do receptor de endotelina para o tratamento de doenças tumorìgenas | |
HUP9802066A2 (hu) | Alendronát alkalmazása csigolyát nem érintő csonttörések kockázatát csökkentő gyógyszerkészítmények előállítására | |
BR0311146A (pt) | Uso de tibolona e de modulador de receptor de estrogênio seletivo, e, método e kit para o tratamento de um sintoma relacionado com a deficiência de estrogênio em um paciente do sexo feminino | |
CA3100422A1 (en) | Dosing regimens for treatment of solid tumors having one or more genetic alterations in fgfr1, fgfr2, and/or fgfr3 | |
HUP0302293A2 (hu) | Rák kezelése aplidin és egy izomvédő szer együttes alkalmazásával | |
HUP0003159A2 (hu) | N-monoszubsztituált-3-oxo-4-aza-5alfa-androszt-1-én-17béta-karboxamidok alkalmazása gyógyászati készítmények előállítására | |
AU2005251573B2 (en) | Use of 7-t-butoxyiminomethylcamptothecin for treating uterine neoplasms | |
HUP0401731A2 (hu) | N,N-dietil-2-[4-(fenilmetil)-fenoxi] etánamin-monohidroklorid (DPPE) alkalmazása a rákterápiában használható gyógyszer előállítására | |
ITMI980356A1 (it) | Composizioni orali a basso dosaggio di proteine citotossiche | |
NZ538926A (en) | Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases | |
OKABE et al. | A case of a solitary fibrous tumor of the oral cavity | |
徐兵河 et al. | THE CLINICAL COURSE AND TREATMENT RESULTS OF LUNG METASTASES FROM BREAST CANCER | |
Houghton et al. | Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer | |
Baum et al. | Arimidex, tamoxifen alone or in combination (ATAC) adjuvant trial in post-menopausal breast cancer | |
Chmielowski et al. | Skin Cancers | |
AU2002226287A1 (en) | Expression of keratin genes 8 and 18 for treating tumours, in particular a mammary carcinoma | |
NAKAGAWA et al. | Three cases of metastatic lung carcinoma to the oral cavity | |
Bahal et al. | Malignant fibrous histiocytoma of maxillary sinus and nasopharyngeal region | |
UA37750A (uk) | Спосіб лікування запальних захворювань пародонту у вагітних жінок |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC4A | Lapse of provisional application due to refusal |